Want to see GOCOQ full AI Analyst Report?
Top Page
GoHealth
(OTC:GOCOQ)
Select Model
Select Model
Rating:39Underperform
Price Target:
$0.35
▼(-74.45% Downside)
Action:Reiterated
Date:06/17/26
The score is driven down primarily by very weak financial performance (sharp revenue decline, extreme losses, high leverage from near-depleted equity, and sizable cash burn) and significant bankruptcy/delisting corporate events that increase the risk of severe dilution or cancellation for common shareholders. Technicals are bearish (price below key moving averages) despite oversold signals, and valuation metrics provide limited support due to negative earnings and no dividend yield provided.
Positive Factors
Recurring commission revenue
GoHealth's core business earns commissions—including ongoing renewal commissions—from Medicare enrollments. That commission-based model creates a structural revenue stream tied to member retention and carrier relationships, supporting predictable cash inflows if enrollments and retention normalize.
Negative Factors
Sharp revenue contraction
A multi-year, large revenue drop erodes scale, reduces carrier negotiation leverage and impairs fixed-cost absorption. Sustained top-line declines materially raise the hurdle to return to profitability and weaken strategic options absent a clear recovery in enrollments.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring commission revenue
GoHealth's core business earns commissions—including ongoing renewal commissions—from Medicare enrollments. That commission-based model creates a structural revenue stream tied to member retention and carrier relationships, supporting predictable cash inflows if enrollments and retention normalize.
Read all positive factors
GoHealth (GOCOQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$10.93M
Dividend YieldN/A
Average Volume (3M)54.81K
Price to Earnings (P/E)―
Beta (1Y)0.68
Revenue Growth-81.69%
EPS Growth-9884.70%
CountryUS
Employees850
SectorFinancial
Sector Strength70
IndustryInsurance - Brokers
Share Statistics
EPS (TTM)-23.06
Shares Outstanding16,686,419
10 Day Avg. Volume90,134
30 Day Avg. Volume54,809
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.29
Price to Sales (P/S)0.08
P/FCF Ratio-0.21
Enterprise Value/Market Cap65.43
Enterprise Value/Revenue4.68
Enterprise Value/Gross Profit7.39
Enterprise Value/Ebitda-1.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-7.26
Revenue Forecast (FY)$252.10M
GoHealth Business Overview & Revenue Model
Company Description
GoHealth, Inc. functions as a prominent digital health enterprise and health insurance marketplace operating across the United States, with a significant focus on Medicare products. Its business is strategically structured into four main divisions...
How the Company Makes Money
GoHealth primarily makes money by acting as a licensed insurance broker/agency and earning commissions from insurance carriers when customers enroll in health insurance plans through its platform and agent channels. The company’s largest revenue s...
GoHealth Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
22
Negative
Cash Flow
24
Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 361.85M | 798.89M | 734.67M | 631.67M | 1.06B |
| Gross Profit | 265.72M | 668.28M | 575.71M | 444.00M | 823.08M |
| EBITDA | -333.66M | 173.71M | 24.10M | -211.55M | -393.21M |
| Net Income | -257.13M | -2.93M | -63.26M | -148.71M | -189.36M |
Balance Sheet | |||||
| Total Assets | 987.38M | 1.49B | 1.50B | 1.66B | 2.07B |
| Cash, Cash Equivalents and Short-Term Investments | 32.90M | 40.92M | 90.81M | 16.46M | 84.36M |
| Total Debt | 672.59M | 527.97M | 543.05M | 557.42M | 696.29M |
| Total Liabilities | 992.70M | 1.03B | 1.04B | 1.07B | 1.18B |
| Stockholders Equity | 94.76M | 294.80M | 280.32M | 318.06M | 353.10M |
Cash Flow | |||||
| Free Cash Flow | -130.19M | -35.34M | 95.41M | 47.39M | -318.81M |
| Operating Cash Flow | -121.95M | -21.61M | 109.14M | 60.90M | -299.01M |
| Investing Cash Flow | -8.25M | 3.81M | -13.73M | -13.51M | -19.80M |
| Financing Cash Flow | 122.00M | -32.03M | -21.11M | -115.05M | 259.09M |
GoHealth Technical Analysis
Negative
1.37
Price Trends
0.61
Negative
1.03
Negative
2.08
Negative
Market Momentum
-0.07
Negative
37.26
Neutral
35.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GOCOQ, the sentiment is Negative. The current price of 1.37 is above the 20-day moving average (MA) of 0.36, above the 50-day MA of 0.61, and below the 200-day MA of 2.08, indicating a neutral trend. The MACD of -0.07 indicates Negative momentum. The RSI at 37.26 is Neutral, neither overbought nor oversold. The STOCH value of 35.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GOCOQ.
GoHealth Risk Analysis
GoHealth disclosed 128 risk factors in its most recent earnings report. GoHealth reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
GoHealth Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $11.42M | 1.12 | 4.56% | ― | ― | ― | |
56 Neutral | $136.05M | 7.93 | 15.28% | ― | 10.29% | ― | |
55 Neutral | $52.69M | -2.64 | 3.57% | ― | -4.28% | -1.93% | |
39 Underperform | $10.93M | -0.02 | -135.15% | ― | -81.69% | -9884.70% |
* Financial Sector Average
GOCOQ
GoHealth
0.37
-5.56
-93.76%
EHTH
Ehealth
1.62
-2.27
-58.35%
HUIZ
Huize Holding
1.32
-1.09
-45.23%
SLQT
SelectQuote
0.77
-1.60
-67.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.